We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current GTBP market cap is 6.03M. The company's latest EPS is USD -3.4001 and P/E is -0.79.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.62M | -3.12M | -3.17M | -3.09M | -3.91M |
| Net Income | -1.99M | -2.42M | -2.96M | -2.27M | -3.71M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.46M | -6.76M | -57.52M | -21.26M | -13.58M |
| Net Income | -18.19M | -28.3M | -58.01M | -20.88M | -7.6M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 18.14M | 16.15M | 14.11M | 9.91M | 9.27M |
| Total Liabilities | 6.38M | 6.14M | 6.63M | 4.6M | 3.76M |
| Total Equity | 11.76M | 10.01M | 7.48M | 5.31M | 5.51M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 396k | 5.66M | 32.17M | 16.74M | 14.11M |
| Total Liabilities | 19.71M | 35.09M | 10.26M | 5M | 6.63M |
| Total Equity | -19.31M | -29.43M | 21.91M | 11.73M | 7.48M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.84M | -6.81M | -8.85M | -4.16M | -7.7M |
| Investing | -4.33M | -2.49M | -2.01M | 5.03M | 12.89M |
| Financing | 6.27M | 6.27M | 6.27M | N/A | 2.98M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.66M | -7.26M | -15.61M | -15.22M | -8.85M |
| Investing | 200k | N/A | -23.04M | 12.15M | -2.01M |
| Financing | 3.43M | 12.53M | 42.32M | -224k | 6.27M |
| Market Cap | 6.03M |
| Price to Earnings Ratio | -0.79 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.59 |
| Price to Book Ratio | 0.81 |
| Dividend Yield | - |
| Shares Outstanding | 2.23M |
| Average Volume (1 week) | 19.99k |
| Average Volume (1 Month) | 24.41k |
| 52 Week Change | -58.14% |
| 52 Week High | 10.6599 |
| 52 Week Low | 1.9201 |
| Spread (Intraday) | 0.08 (2.88%) |
| Company Name | GT Biopharma Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.gtbiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
